Fmr LLC Buys 45,174 Shares of Chemed Co. (NYSE:CHE)

FMR LLC lifted its stake in shares of Chemed Co. (NYSE:CHE - Free Report) by 18.9% during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The fund owned 283,790 shares of the company's stock after acquiring an additional 45,174 shares during the period. FMR LLC owned 1.89% of Chemed worth $150,352,000 as of its most recent SEC filing.

Several other institutional investors and hedge funds have also modified their holdings of CHE. Norges Bank purchased a new position in Chemed in the fourth quarter valued at about $95,872,000. Raymond James Financial Inc. bought a new stake in shares of Chemed in the 4th quarter worth approximately $42,023,000. Principal Financial Group Inc. grew its stake in Chemed by 114.1% during the 4th quarter. Principal Financial Group Inc. now owns 74,658 shares of the company's stock worth $39,554,000 after buying an additional 39,791 shares during the last quarter. Segall Bryant & Hamill LLC bought a new position in shares of Chemed during the fourth quarter worth about $12,880,000. Finally, Boston Trust Walden Corp grew its position in Chemed by 10.0% in the 4th quarter. Boston Trust Walden Corp now owns 242,172 shares of the company's stock worth $128,303,000 after purchasing an additional 22,105 shares during the last quarter. Hedge funds and other institutional investors own 95.85% of the company's stock.

Chemed Stock Performance

Shares of CHE stock traded down $12.42 during mid-day trading on Tuesday, reaching $588.27. The company's stock had a trading volume of 106,219 shares, compared to its average volume of 97,457. The firm's 50-day moving average is $584.60 and its two-hundred day moving average is $567.87. The company has a market cap of $8.60 billion, a P/E ratio of 29.73, a PEG ratio of 2.15 and a beta of 0.49. Chemed Co. has a 1-year low of $512.12 and a 1-year high of $623.61.

Remove Ads

Chemed Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Friday, March 14th. Shareholders of record on Monday, February 24th were paid a $0.50 dividend. This represents a $2.00 dividend on an annualized basis and a dividend yield of 0.34%. The ex-dividend date was Monday, February 24th. Chemed's dividend payout ratio is presently 10.05%.

Insiders Place Their Bets

In other news, CEO Kevin J. Mcnamara sold 1,000 shares of Chemed stock in a transaction on Monday, March 31st. The shares were sold at an average price of $615.33, for a total transaction of $615,330.00. Following the transaction, the chief executive officer now directly owns 101,679 shares of the company's stock, valued at $62,566,139.07. This trade represents a 0.97 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is available through this hyperlink. Company insiders own 3.32% of the company's stock.

Analyst Ratings Changes

Several equities analysts have recently issued reports on the company. Royal Bank of Canada lifted their price target on Chemed from $633.00 to $667.00 and gave the company an "outperform" rating in a research report on Friday, March 14th. StockNews.com raised Chemed from a "hold" rating to a "buy" rating in a research note on Friday, March 7th.

Chemed Profile

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.